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THE EFFECTS OF MODERATE ALCOHOL CONSUMPTION AND INFLAMMATION ON THE 
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Christine E. Dolin 
04/12/2017 
 
 Background.  The association of chronic ethanol (EtOH) consumption with extracellular 
matrix (ECM) changes in alcoholic liver disease (ALD) is well established in the context of hepatic 
fibrosis.  However, it is becoming increasingly understood that the hepatic ECM responds 
dynamically to stress well before fibrosis.  The term “transitional tissue remodeling” describes 
qualitative and quantitative ECM changes in response to injury that do not alter the overall 
architecture of the organ; these ECM changes may contribute to early disease initiation and/or 
progression.  The nature and magnitude of these changes to the ECM are currently poorly 
understood.  In contrast to the liver, EtOH consumption is not considered a risk factor for disease 
in the kidney.  However, the effects of ethanol on the kidney at a molecular level are largely 
unknown.  Methods.  The goal of this work was to characterize the impact of 6 weeks EtOH diet 
and/or acute lipopolysaccharide (LPS) on the hepatic ECM proteome (‘matrisome’) and the renal 
cortex proteome.  Liver sections were processed in a series of increasingly rigorous extraction 
buffers to separate proteins by ‘age’ and crosslinking.   Kidney cortex proteins were extracted in 
lysis buffer.  Extracted proteins were identified using liquid chromatography-tandem mass 
spectrometry (LC-MS/MS).  Results.  Both EtOH and LPS dramatically increased the number of 
hepatic matrisome proteins ~25%.  The enhancement of LPS-induced liver damage by ethanol 
preexposure was associated with unique protein changes.  In the renal cortex, 170 of 1863 
proteins were significantly differentially abundant at FC ≥ 1.2 across groups.  Ingenuity Pathways 
Analysis results show EtOH dysregulated the Nrf2-mediated pathway.  Western blot and 
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immunohistochemistry of Nrf2 target proteins validate proteomic findings.  Transcriptomic 
analysis of the renal cortex reinforce proteomic findings and provide additional insight into Nrf2 
pathway regulation. 
Conclusions. An extraction method to enrich the hepatic ECM was developed and characterized.  
The results demonstrate that the hepatic matrisome responds dynamically to both acute (LPS) 
and chronic (ethanol) stresses, long before more dramatic fibrotic changes to the liver.  These 
changes may contribute, at least in part, to the pathologic responses to these stresses.  It is also 
interesting that several ECM proteins responded similarly to both stresses, suggesting a common 
mechanism in both models.  The study on the effects of EtOH and/or LPS on the renal 
transcriptome and proteome supported expected observations and revealed new changes in 
proteins, transcripts, and pathways. These changes provide insight into mechanisms by which 
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Although the structural role of the extracellular matrix (ECM) is well known, this compartment 
contains a diverse range of components that work bi-directionally with surrounding cells to create 
a dynamic and responsive microenvironment that regulates cell and tissue homeostasis.  The 
ECM components (i.e., ‘matrisome’) play a key role in signaling via interactions with cell-surface 
receptors.  The ECM also indirectly impacts cell-to-cell communication by binding and retaining 
soluble mediators including cytokines, chemokines, and growth factors.(1)  Proteases and 
protease inhibitors associated with the ECM also contribute to maintaining its homeostasis, as 
well as mediating its changes in response to stress or injury.(2)   
In some contexts, changes to the ECM are well-recognized and understood; for example, the 
formation of collagenous scars in tissue is almost a canonical response to unresolved chronic 
injury.  Hepatic fibrosis is a well-known example of this scarring process, (3) as fibrotic livers 
develop easily detectable collagenous scars.  Given the dominance of these changes in the 
hepatic ECM during fibrogenesis, many studies have focused on the mechanisms that underlie 
the increases in collagen deposition.  However, the alterations of the hepatic ECM during fibrosis 
are much more diverse than simply an increase in collagen.  Indeed fibrosis is characterized by 
changes in the deposition and distribution of a myriad of other ECM proteins (e.g., laminin and 
vitronectin).(4)  Whereas many of these changes are described, there are still gaps in our 
understanding. 
ECM remodeling is not solely relegated to chronic fibrogenesis, but also contributes to early 
injury responses in tissue; a well-known example of the latter is the wound healing response.    
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The term “transitional tissue remodeling” describes changes to the ECM that do not alter the 
overall architecture of the organ (Figure 2A).  For example, changes in the expression of ECM 
proteins such as fibronectin (5) and fibrin (6;7) have been observed in models of hepatic 
inflammation.  Importantly, blocking these ECM changes blunts, at least in part, hepatic injury in 
these models.  Therefore, transitional changes to the ECM may contribute to early disease 
initiation and/or progression prior to the onset of fibrogenesis (Figure 2A).  The nature and 
magnitude of these changes to the ECM are currently poorly understood.  A better understanding 
could elucidate new mechanisms and/or biomarkers for diseases. 
Although previous studies have shown that subtle changes in the ECM may contribute to 
the development of inflammatory liver injury, the research in this area has generally been 
restricted to study of single ECM proteins (e.g., fibrin)(6;7).  A more ‘omic approach has been 
previously hampered by the difficulties associated with the low abundance and insolubility of 
many ECM proteins.  Therefore, a goal of this study was to develop a multi-step liver extraction 
that would allow for the enrichment and solubilization of ECM proteins.  A second goal of this 
work was to use a proteomic approach to determine global changes in the ECM in models of 
inflammatory liver damage.   
Chronic, heavy ethanol consumption causes kidney damage secondary to hepatic 
cirrhosis, a phenomenon known as hepato-renal syndrome.  Moderate alcohol consumption, 
however, is currently not considered a risk factor for chronic kidney disease.  Furthermore, 
population based studies have shown moderate alcohol consumption to be inversely associated 
with kidney injury (8).  However, the direct renal effects of chronic moderate EtOH consumption 
and sensitization to secondary hits are unclear.  Rodent studies have identified several 
mechanisms of alcohol-induced kidney injury that parallel those observed in the liver (9-11).  
These investigations have been driven by the hypothesis that alcohol affects the kidneys similarly 
to the liver.  It certainly is not surprising that these parallel mechanisms have been confirmed, 
considering similarities between these two organs, such as the expression of CYP2E1(9).   
However, the liver and kidney also have many significant differences in structure, 
function, and composition.  Therefore, it is reasonable to hypothesize that moderate alcohol   
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consumption has effects on the kidney that do not parallel mechanisms of hepatotoxicity, 
especially, perhaps, with respect to alteration of organ response to a second inflammatory 
stimulus.  Efficiently elucidating such unknown mechanisms calls for an unbiased, discovery-
based approach.  Accordingly, we propose global discovery-based proteomic and transcriptomic 
investigation of the effects of alcohol preexposure on the response of the renal cortex to 
lipopolysaccharide (LPS), a prototypical inflammatory stimulus.    
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MATERIALS AND METHODS 
 
Animals and Exposures  
Mice were housed in a pathogen-free barrier facility accredited by the Association for 
Assessment and Accreditation of Laboratory Animal Care, and procedures were approved by the 
University of Louisville’s Institutional Animal Care and Use Committee.  For sacrifice, animals 
were anesthetized with ketamine/xylazine (100/15 mg/kg, i.p.) and blood was collected from the 
vena cava just prior to sacrifice.  Citrated plasma was stored at -80⁰C for further analysis and 
sections of liver and kidney tissue were snap-frozen in liquid nitrogen, frozen-fixed in OCT-
Compound (Sakura Finetek, Torrance, CA), or were fixed in 10% neutral buffered formalin for 
subsequent sectioning and mounting on microscope slides.  Paraffin-embedded, formalin fixed 
samples were stained with Sirius Red/Fast Green to visualize fibrosis (CCl4 study)(12).  CCl4 
exposure.  Male (4-6 w) C57BL/6J mice were purchased from Jackson Laboratory (Bar Harbor, 
ME).  Mice were administered CCl4 (1 ml/kg i.p.; diluted 1:4 in olive oil; Sigma-Aldrich, St. Louis, 
MO) twice a week for 4 weeks.(12)  Ethanol exposure.  Male (8 w) C57BL6/J mice were 
purchased from Jackson Laboratory (Bar Harbor, ME).  Mice were fed ethanol-containing Lieber 
DeCarli diet ad libitum or pair fed isocaloric/isovolumetric maltose-dextrin control diet.(13)  EtOH 
concentrations in the diet were as follows: 0% for two days, 1% for two days, 2% for two days, 
4% for 1 week, 5% for one week, and 6% for three weeks. After 6 weeks of feeding, animals were 
injected with either LPS (E. coli; 10 mg/kg i.p., Sigma, St. Louis, MO) or vehicle (saline), and 
euthanized 4 or 24 h later.(13) (Figure 1).   
Hepatic ECM Proteomic Analysis 







Figure 1: Chronic ethanol 2-hit model of liver injury. 
Mice were fed ethanol-containing Lieber DeCarli diet or isocaloric/isovolumetric 
maltose-dextrin diet for 6 weeks and were injected with LPS (10 mg/kg i.p.) or 







described by de Castro Bras et al. for heart tissue,(14) with minor modifications such as not 
pooling the final solubilized pellet with the GnHCl fraction(Figure 2).   
Samples were separated on Dionex Acclaim PepMap 100 75  uM x 2cm nanoViper (C18, 
3µm, 100Å) trap and Dionex Acclaim PepMap RSLC 50uM x 15 cm nanoViper (C18, 2µm, 100Å) 
separating columns.  An EASY n-LC (Thermo) UHPLC system was used with buffer A = 2% v/v 
acetonitrile / 0.1% v/v formic acid and buffer B = 80% v/v acetonitrile / 0.1% v/v formic acid as 
mobile phases.  A Nanospray Flex source (Thermo) was used to position the end of the emitter 
near the ion transfer capillary of the mass spectrometer.  An Orbitrap Elite – ETD mass 
spectrometer (Thermo) was used to collect data from the LC eluate.  An Nth Order Double Play 
with ETD Decision Tree method was created in Xcalibur v2.2.   
 
Hepatic ECM Proteomic Data Analysis 
Proteome Discoverer v1.4.0.288 was used to analyze the data collected by the mass 
spectrometer.  The database used in Mascot v2.4 and SequestHT searches was the 6/2/2015 
version of the UniprotKB Mus musculus reference proteome canonical and isoform sequences.  
Carbamidomethylation (+57 on C) was selected as a fixed modification, and Asn->Asp (+1 on N) 
and Met or Pro oxidation (+16) were selected as variable modifications.  A maximum of two 
missed cleavages were allowed.  In order to estimate the false discovery rate, a Target Decoy 
PSM Validator node was included in the Proteome Discoverer workflow.  The results were 
annotated with mouse gene ontology (GO) information from the Gene Ontology Annotations 
Database.  Additional analysis of extracellular proteins were further categorized into four classes 
based on their role in the extracellular space as determined by a comprehensive literature search.  
These four ECM groups include: (1) glycoproteins and proteoglycans, (2) other ECM-associated 
proteins, (3) proteases and protease inhibitors and (4) collagens.  If no record could be found 
supporting the hypothesis that a protein was associated with the ECM, the protein was placed 






Renal Cortex Proteomic Analysis 
Renal cortex proteins were extracted in lysis buffer (1:1 w/v) containing 10% glycerol, 
50mM HEPES, 100mM KCl, 2mM EDTA, 0.1% Nonidet p-40 (NP40), 2mM DTT, 10mM NaF, 
0.25 mM NaVO3, and protease inhibitors.  Samples were placed in a sonication bath for 5 
minutes and incubated on ice for 1 hour.  Extract was removed from insoluble matter after 
centrifugation at 12,000×g for 30 minutes.   
Renal cortical proteins (100µg) were digested using a Filter-Aided Sample Preparation 
(FASP) protocol developed by Jacek R. Wisniewski, et al. (15) to remove excess SDS detergent 
used for sample preparation.  Proteomic analysis of tissue lysates were conducted as previously 
described (16) with the following exceptions.  Proteins were digested with Lys-c (1:100 w:w rLys-
C: protein ratio) and trypsin (1:100 w:w trypsin:protein ratio.  Peptides were desalted using HLB 
extraction (Waters Oasis HLB 1cc, WAT094225) as described by Keshishian, et al (17). 50 µg 
peptide were dried and resuspended in 100µL 100mM triethylammonium bicarbonate (TEABC).  
Peptide concentrations were measured using an A205 nm assay with external bradykinin 
standard curve.   
Samples were prepared to a concentration of 0.5µg/µL in 100 mM TEABC.  Tandem 
mass tag (TMT) 10-plex labeling (Thermo 90111) was carried out according to manufacturer’s 
instructions using 50µg peptide per label tube.  Labeled samples were admixed and stored at -80 
°C.  Samples were then dried and resuspended in 800µL 0.1% v/v formic acid.  Peptides 
underwent HLB extraction as described above.  HLB eluates were dried and resuspended in 
100µL 2% v/v acetonitrile 0.1% v/v formic acid.  Peptide concentrations were measured as 
described above.   
200µg peptide were fractionated by strong cation exchange using 30-300µg capacity 
SCX MacroSpin Columns (SMM HIL-SCX.25, the Nest Group, Inc. Southborough, MA, USA) 
according to manufacturer’s instructions.  Sample cleanup was performed using C18 PROTO, 
300 Å Ultra Microspin Columns (the Nest Group, Inc., Southborough, MA, USA).  1D-LCMS 
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analysis was carried out using a Proxeon EASY-nLC 1000 UHPLC and nanoelectrospray 
ionization into an Orbitrap Elite mass spectrometer (Thermo).   
 
Renal Cortex Proteomic Data Analysis 
Mass spectrometry data were analyzed using Proteome Discoverer v1.4.0.288 and 
Scaffold Q+S v4.3.2.  The database used in Mascot v2.4 and SequestHT searches was the 
6/2/2014 version of the UniprotKB Mus musculus reference proteome canonical and isoform 
sequences.  In order to estimate the false discovery rate, a Target Decoy PSM Validator node 
was included in the Proteome Discoverer workflow.  A Reporter Ions Quantifier node was 
included for quantification of the TMT reporter ions.  TMT purity correction factors were obtained 
from the manufacturer.  The resulting .msf files from Proteome Discoverer were loaded into 
Scaffold.  Intensity based normalization of reporter ions was done using the mean calculation 
type, modeled on unique peptides, and using an average protein reference.  Scaffold was used to 
calculate the false discovery rate using the Peptide and Protein Prophet algorithms.  Data were 
filtered by Benjamini-Hochberg (BH) corrected ANOVA p-value <0.05 and fold change (FC) ≥ 1.2.  
Ingenuity Pathways Analysis (IPA) was used to identify pathways changed by EtOH, LPS, and/or 
the combination.  
 
Renal Cortex RNA Seq Analysis 
Snap frozen renal cortex sections were stored at -80° C.  Samples were placed in 
RNAlater-ICE (Life Technologies, Carlsbad, CA) and incubated at -20° C for 72 hours prior to 
RNA extraction.  RNA was isolated using the mirVana kit (Life Technologies, Carlsbad, CA) 
according to manufacturer’s instructions for total RNA isolation.  RNA quality was evaluated by 
Nanodrop ND-1000 (Thermo Fisher Scientific, Grand Island, NY) and Agilent 2100 Bioanalyzer 
(Agilent, Santa Clara, CA) analysis.  Ribosomal depletion was carried out prior to RNA seq 
analysis.  RNA libraries were prepared using the TruSe Stranded Total RNA LT sample 
preparation Kit- Set A with Ribo-Zero Gold.  Sequencing was performed on the University of 
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Louisville Center for Genetics and Molecular Medicine’s (CGeMM) Illumina NextSeq 500/550 75 
cycle High Output Kit v2.   
RNA Seq data were analyzed using the Tuxedo suite data analysis pipeline.  
Differentially expressed transcripts were identified by filtering by ANOVA p-value cutoff (p<0.05), 
a more stringent BH q-value cutoff (q<0.01) and fold change cutoff of 1.2. 
 
Renal Cortex Immunoblots, Immunohistochemistry, and Catalase Activity Assay 
Immunoblots were carried out as described previously (16) using primary antibodies 
against NQO1 (Abcam ab80588), SOD1 (Santa Cruz sc11407), GCLC (γ-GCSc, Santa Cruz 
sc22755), and catalase (Cell Signaling D5N7V). 
Immunohistochemistry was carried out using primary antibodies against fibronectin 
(Santa Cruz sc-8422) and catalase (Cell Signaling D5N7V).   
Catalase activity in 0.8 µg renal cortex lysate was measured based on metabolism of 






Analysis of changes to the ECM proteome caused by CCl4-induced hepatic fibrosis.  
Previous studies have investigated the matrisome profile for aortic vessel and cardiac tissue 
(14;18).  However, this method has never been employed for liver tissue.  The first goal of this 
work was therefore to validate this approach for hepatic tissue in a model that causes robust 
changes to the hepatic ECM (i.e., fibrosis).  Specifically, the impact of 4 weeks CCl4 exposure 
(see Methods) on the ECM proteome was determined (Figure 3).  As expected (12), CCl4 
exposure caused robust ECM deposition that was easily detected with standard collagen stains 
(Sirius Red/Fast Green; Figure 3A) and immunoblotting (Figure 3B).  A similar increase in 
collagen 1α1 was detected via LC-MS/MS (Figure 3C).  Exposure to CCl4 increased the levels of 
collagens type III, IV, and V (Figure 3C).  However, analysis showed only minor qualitative 
changes in the ECM proteome in CCl4 exposure when the fractions were informatically collapsed.  
When the fractions were collapsed, CCl4 exposure increased the number of proteins associated 
with the ECM by 7, and only 1 protein was lost compared to the control group (data not shown).   
 
Ethanol and LPS exposure cause global changes to the hepatic matrisome. 
Standard proteomic analysis generally employs a direct analysis of total protein in the 
absence of additional fractionation steps.  To simulate this, the fractions were artificially collapsed 
post hoc, and quantitative changes in the ECM proteome between the four exposure groups 
(±Ethanol diet, ±24h LPS injection) were compared in a heatmap (Figure 4A); the most 
upregulated or downregulated ECM proteins normalized to control were used to compare the 







Figure 2: Scheme of transitional ECM changes and extraction methodology.  
Remodeling in response to chronic injury (i.e., fibrosis) is well-known; however the 
hepatic extracellular matrix (ECM) also responds dynamically to acute stress.  
These acute responses can be viewed as an arm of the wound healing response 
and facilitate recovery from damage, which resolves once the damage is repaired.  
However, under conditions of chronic injury, these changes contribute to activation 





























Figure 3: Validation of ECM extraction technique with CCl4 model of hepatic 
fibrosis. 
Animals were administered CCl4 or vehicle for 4 weeks. Collagen type I 
accumulation was determined by Sirius Red staining (Panel A) and by dot blot 
(Panel B). Quantitative changes in other collagens was also determined in the 
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Figure 4: Liver extracts have unique protein profiles based on fraction type 
and experimental group.   
A heatmap depicting quantitative changes to the total ECM proteome in response 
to ethanol and/or 24h LPS compared to control is shown in Panel A.  The number 
of proteins unique to or shared by all four extractions of control animals is shown 
(Panel B).  Bubble graphs are used to show presence of plasminogen, annexin A1 
and fibrin(ogen) gamma chain across the four extracts (x-axis) and the four 











































































































































between the control group and exposure groups, with ethanol and LPS exposure groups 
producing varying patterns and the combination of the ethanol/LPS producing shared patterns 
similar to both exposures alone, but also demonstrated unique patterns (Figure 4A).  However, 
similar to the results with samples from CCl4 (Figure 3), there were few proteins that changed 
qualitatively in response to ethanol and/or LPS.    
 
3-step serial extraction creates distinct protein profiles.  
ECM proteins are not only regulated at the level of de novo synthesis, but at the level 
enzymatic activation, degradation and crosslinking.  Previous studies have employed a 3-step 
ECM purification method (Figure 2) in other organs and that approach was adapted for use with 
liver tissue here.(14;18)  The NaCl extraction displaces polyionic interactions between proteins, 
thereby solubilizing loosely-bound proteins.(19)  Following NaCl extraction, the remaining liver 
tissue was decellularized using 1% SDS.  SDS solubilizes cytoplasmic and nuclear membranes, 
allowing for the release of cellular proteins.  Decellularization was followed by a denaturing step 
with 4 M guanidine HCl (GnHCl) buffer.(20)  Following the denaturing extraction, an insoluble 
pellet enriched in heavily cross-linked matrix proteins remained.(18)  Analysis of the extractions of 
the CCl4 samples for collagen isoforms (Figure 3C) indicated that, as expected, these proteins 
tended to accumulate in the later extraction fractions.  The separation of ECM proteins into each 
of the four extracts in livers from control animals were qualitatively compared (Figure 4B).  Each 
extract yielded a distinct ECM protein profile consisting of not only ECM proteins that were shared 
among all four extracts, but also proteins unique to particular extracts (Figure 4B).  These results 
indicate that the extraction approach was effective at separating ECM proteins. 
When ECM proteins were compared between experimental groups, interesting patterns 
of accumulation in the extracts were revealed (Figure 4C).  For example, some proteins (e.g., 
plasminogen) changed in overall “presence” or “absence” in response to exposures but localized 
consistently to the same fraction when present.  Other proteins exhibited more complex 
responses, also changing in fractionation pattern.  For example, whereas annexin A1 was found 






Figure 5: Ethanol and LPS cause dynamic changes in the hepatic 
matrisome.   
The impact of ethanol diet (left panels) and 24 h LPS (right panels) on the types of 
proteins found in the ECM proteome are shown.  Proteins are categorized by class 
(Panels A-D) and organized by extraction fraction (NaCl, SDS, GnHCl and pellet).  
Red bars indicate proteins that appeared with exposure, while green bars indicate 
those that were lost with exposure, compared to control.   
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Figure 6: Shared and unique changes to the hepatic matrisome.   
Venn diagrams (left column) show all proteins within an extract and indicate the 
number that are shared between or that are unique to the four experimental 
groups.  Bubble plots (right column) show quantitative changes in abundance of 
proteins that were shared by all four experimental groups.  The bubble plots 
show fold change in protein expression caused by LPS (y-axis), ethanol (x-axis), 
and the combination of ethanol + LPS (bubble size).  Each bubble represents a 









Figure 7: Quantitative changes to the hepatic matrisome.   
Heatmap analysis of the quantitative changes in abundance of proteins that were 
shared by all four experimental groups (See Figure 6) are shown for the NaCl 
(panel A), SDS (panel B), GnHCl (panel C) and pellet (panel D) extraction 
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exposed to ethanol or LPS alone; however, the combination of ethanol and LPS caused this 
protein to accumulate in the NaCl fraction.  Similarly, fibrin(ogen) gamma chain was found in all 
treatment groups, but its fractionation pattern was unique to each exposure condition.  These 
patterns likely represent differences in the synthesis, degradation and/or maturity of the ECM 
proteins. 
 
Qualitative changes to the hepatic ECM proteome in response to stress 
Figure 5 summarizes the abundance of proteins, organized by category (i.e., glycoproteins 
and proteoglycans, ECM associated proteins, proteases and inhibitors and collagens) across the 
4 extraction conditions based on Naba et al. (21)or other sources.  The majority of the proteins in 
the NaCl and SDS extracts were ECM-associated proteins (class 2; Figure 5B); this was 
expected, as these are generally loosely associated with the extracellular matrix and are easily 
solubilized.  Additionally, the low abundance of collagens in the NaCl and SDS fractions (Figure 
5D) was not surprising, as collagens are often tightly cross-linked and require denaturing 
conditions for solubilization.  As expected, the denaturing conditions created by GnHCl more than 
doubled the number of proteoglycans and glycoproteins in the GnHCl extract compared to the 
NaCl and SDS fractions.  The number of collagens in the GnHCl extract was also dramatically 
increased compared to the NaCl and SDS fractions.  The pellet fraction contained the fewest 
proteins of all four extracts; this fraction has the greatest number of collagens.   
Ethanol and LPS, alone or combined, did not change the general pattern of proteins found in 
the various extracts (Figure 5), but both tended to increase the total number of ECM proteins in 
the fractions combined.  For example, ethanol exposure caused a net increase in the number of 
ECM proteins by ~25%.  These changes were predominantly spread across the first 3 protein 
classes with the NaCl, SDS and GnHCl extracts all increasing to a similar extent.  The least 
responsive protein class were the collagens (Figure 5D).  Likewise, the pellet fraction responded 
the least dynamically to ethanol or LPS exposure and actually showed a net loss in total proteins.  
Figure 6 (left panels), shows the distribution of the proteins in the various extracts between all 4 
exposure groups.   
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In addition to proteins that changed in their extraction pattern in response to ethanol (e.g., 
see Figure 4C), there were several proteins whose presence was unique to ethanol exposure 
compared to control (Figures 5 and 6); these include fibrin(ogen) α and β chains, cytokeratin 13, 
vitronectin, plasminogen, high mobility group protein B2, and collagens IVα2 and Vα2.  Likewise, 
LPS exposure caused the appearance of several proteins that were unique compared to control 
(Figures 5 and 6).  Several of these proteins were shared with ethanol exposure, but there were 
also several that were unique, including serpine B5 (maspin), serine protease inhibitor A3N 
(Serpin A3N), and CXC motif chemokine 9 (CXCL9) (Figure 6). 
Previous work has shown that ethanol pre-exposure sensitizes the liver to inflammatory 
injury caused by a second insult (i.e. LPS) (22;23).  Furthermore, previous studies have 
suggested that changes in the ECM composition can contribute to the sensitizing effect of ethanol 
pre-exposure(6).  In this study, the combination of chronic ethanol exposure and a second hit of 
LPS caused unique changes in the ECM protein profile of the liver.  The combination of EtOH + 
LPS resulted in the appearance of 4 unique proteins that were not present in livers from animals 
exposed to either ethanol or LPS alone, including serum amyloid P and serpine B9.   
 
Quantitative changes to the hepatic ECM proteome caused by stress.  
Dramatic changes to the ECM (i.e., “lost” or “gained”) can significantly impact overall organ 
function; it is not surprising that the majority of the matrisome did not change at the qualitative 
level.  However, several of these proteins did change in relative abundance in response to 
ethanol and/or LPS (Figures 6 and 7).  According to clustering analysis (data not shown) of each 
fraction, six clusters were identified as the best visual representation of the data.  Notable (>4-fold 
increase) changes caused by LPS included ferritin heavy chain (15-fold increase) in the NaCl 
fraction, haptoglobin and myosin-9 (11- and 9-fold, respectively) in the SDS fraction, and 
fibrinogen γ chain and haptoglobin (14- and 7-fold, respectively) in the GnHCl fraction.  Likewise, 
ethanol exposure changed the abundance of several proteins, including myosin-9 (6-fold) and 
cysteine-rich with EGF-like domain protein 2 (CREDL2; 6-fold) in the SDS fraction.  As was 
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observed for qualitative analysis (Figure 5), proteins in the pellet fraction responded the least to 
ethanol and/or LPS.   
In addition to the effects of ethanol and LPS, there were also proteins that responded 
uniquely to the combination of the 2 exposures.  For example, although LPS alone did not change 
endoplasmin abundance compared to control, and ethanol only increased endoplasmin 
abundance 3-fold, the combination of ethanol and LPS increased the abundance of this protein 
11-fold in the NaCl fraction (Figures 5 and 6).  A similar effect was seen on granulin abundance in 
the SDS fraction, which was increased by 5-fold by ethanol and LPS despite no effect by ethanol 
alone and only a 2-fold increase by LPS (Figures 5 and 6).  Additionally, although both LPS and 
ethanol alone increased CRELD2 the combination of ethanol + LPS actually decreased the levels 
in the SDS fraction.  In the GnHCl fraction, proteins that were differentially regulated by the 
combination of ethanol and LPS include hemopexin and alpha-1-microglobulin/bikunin precursor 
(AMPB).  
 
EtOH and/or LPS cause little change to renal cortex morphology 
No difference or little histological difference was seen in renal cortexes from mice 
exposed to EtOH, LPS, or the combination, as shown by periodic acid-Schiff (PAS) stain (Figure 
8).  Cortexes from EtOH fed mice had no detectable differences (Figure 8A).  Cortexes from mice 
injected with LPS after EtOH or pair feeding had minor polymorphonuclear leukocyte infiltration in 
the interstitial and glomerular space as well as tubular dilation, increased vacuolization, and 
tubular brush border loss (Figure 8B).   
 
EtOH and LPS each cause unique protein abundance patterns in renal cortex 
170 of 1863 proteins were significantly differentially abundant at FC ≥ 1.2 across groups 
(Figure 9).  Figure 10 shows the top pathways changed by EtOH compared to control, LPS 
compared to control, EtOH+LPS compared to LPS, and EtOH+LPS compared to EtOH.  The 
NRF2-mediated oxidative stress response canonical pathway was the pathway with the largest 
predicted directional change caused by EtOH consumption.  The Nrf2 pathway had a negative z 
score with EtOH exposure (Figure 10A), which indicates overall pathway deactivation.  This z 
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score was based on the change of abundance of many Nrf2 pathway-related proteins in a 
direction opposite what would be expected if the pathway was activated (Table 1).  However, 
NAD(P)H quinone dehydrogenase 1 (NQO-1) abundance changed in an opposite direction, 
consistent with Nrf2 pathway activation (Table 1).  Western blot analysis of Nrf2 target proteins 
validates proteomic findings (Figure 11), and catalase activity decreased in a similar pattern to 
the decrease in catalase abundance.   
 
RNA seq data reinforce proteomic findings 
22 transcripts were upregulated and 44 transcripts were downregulated with EtOH alone 
at FC ≥ 2 and q-value ≤ 0.05 (Data not shown).  The majority of the effects, however, were LPS-
derived, with 1,141 transcripts upregulated and 673 transcripts downregulated with LPS alone at 
the same level of stringency.  Since the proteomic data showed that EtOH caused a significant 
negative change in the Nrf2-mediated oxidative stress response pathway, a targeted pathways 
analysis was carried out examining the transcript changes in this pathway caused by EtOH (Table 
2).  GCLC and SOD1 transcripts were downregulated, just as the corresponding proteins were 
downregulated.  NQO1 was upregulated as the protein was upregulated.  Many other members of 
the Nrf2-mediated oxidative stress pathway were detected in the transcriptomic data, including 


























Figure 8: Periodic Acid–Schiff (PAS) staining of renal cortex to evaluate the 
effects of ethanol and LPS. 
PAS staining was carried out on renal cortex tissue from mice exposed to ethanol 
and/ or 4h LPS.  Differences in tubular dilation, vacuolization, tubular brush 
border loss and polymorphonuclear leukocyte (PMN) infiltration into interstitial 























































Figure 9: Renal proteome differences by EtOH and LPS exposure.   
Protein abundances were estimated with normalized TMT reporter ion data using 
Scaffold Q+S. Volcano plots were used to filter for large effects of EtOH (9A) and 
LPS (9B) on protein abundance as primary insults compared to Ctl.  A Benjamini-
Hochberg (BH)-corrected p-value of 0.001 and a log2FC of 1.2 were used as filters 
to eliminate proteins from further consideration in emergent properties analysis by 
Ingenuity Pathways Analysis (IPA).
Renal Cortex Proteome
Log2(4h LPS/Ctl)







































































































































































































































































































































































































































Figure 10: IPA canonical pathways changed by EtOH and/or LPS based on 
protein fold change (FC).   
Gene accessions numbers for significant differentially regulated proteins were 
analyzed by IPA to determine regulated canonical pathways.  Pathways received 
a z-score based on the direction of the regulation.  Canonical pathways changed 
by ethanol vs. control (10A), 4h LPS vs. control (10B), EtOH+LPS/LPS (10C), 


















Symbol Entrez Gene Name Ensembl Exp Log Ratio 
Exp FDR (q-
value) Expected 
ACTB actin beta Actb -0.130 7.40E-03   
CAT catalase Cat -0.760 9.00E-05 ↑Up 
CBR1 carbonyl reductase 1 Cbr1 0.120 5.30E-03 ↑Up 
DNAJC13 
DnaJ heat shock protein family 
(Hsp40) member C13 Dnajc13 -0.160 6.50E-03   
GCLC 
glutamate-cysteine ligase catalytic 
subunit Gclc -0.240 9.00E-05 ↑Up 
GCLM 
glutamate-cysteine ligase modifier 
subunit Gclm -0.260 9.50E-03 ↑Up 
GSTP1 glutathione S-transferase pi 1 Gstp1 0.170 3.30E-03   
NQO1 
NAD(P)H quinone dehydrogenase 
1 Nqo1 0.270 9.00E-05   
SOD1 superoxide dismutase 1, soluble Sod1 -0.480 1.70E-03   
SOD2 
superoxide dismutase 2, 
mitochondrial Sod2 0.190 9.00E-05   
STIP1 stress induced phosphoprotein 1 Stip1 -0.200 9.00E-05 ↑Up 
TXNRD1 thioredoxin reductase 1 Txnrd1 -0.100 3.50E-03 ↑Up 
 
Table 1: Proteins used by IPA canonical pathways analysis to predict a 
selective inactivation of the Nrf2-mediated oxidative stress response 
pathway with EtOH compared to control. 
Ethanol-induced pregulation or downregulation of proteins in the Nrf2-mediated 
oxidative stress response pathway contributed to an overall negative z-score 
assigned by IPA.  The “Expected” column contains predicted direction of protein 
abundance if Nrf2 pathway were activated. Bold indicates protein changes 













Symbol Entrez Gene Name Ensembl 
Exp Log 
Ratio 
Exp FDR  
(q-value) Expected 
ABCC4 
ATP binding cassette 
subfamily C member 4 ENSMUSG00000032849 0.658 6.88E-03 ↑Up 
CBR1 carbonyl reductase 1 ENSMUSG00000051483 0.792 6.88E-03 ↑Up 
DNAJB4 
DnaJ heat shock 
protein family (Hsp40) 




subunit ENSMUSG00000032350 -1.386 6.88E-03 ↑Up 
GSTA5 
glutathione S-
transferase alpha 5 ENSMUSG00000074179 0.974 5.65E-02   
HSPB8 
heat shock protein 
family B (small) 
member 8 ENSMUSG00000041548 -0.600 6.58E-01   
MAF 
MAF bZIP transcription 
factor ENSMUSG00000055435 0.504 1.55E-01 ↓Down 
MAFF 
MAF bZIP transcription 
factor F ENSMUSG00000042622 -0.812 4.25E-01 ↑Up 
MGST1 
microsomal glutathione 
S-transferase 1 ENSMUSG00000008540 0.725 6.88E-03   
MGST3 
microsomal glutathione 
S-transferase 3 ENSMUSG00000026688 0.502 1.77E-01   
NFE2L2 
nuclear factor, 
erythroid 2 like 2 ENSMUSG00000015839 0.339 6.50E-01 ↑Up 
NQO1 
NAD(P)H quinone 









factor 1 ENSMUSG00000028066 -0.802 5.63E-01 ↑Up 
SOD1 
superoxide 
dismutase 1, soluble ENSMUSG00000022982 -0.364 5.04E-01   
SQSTM1 sequestosome 1 ENSMUSG00000015837 -0.520 4.66E-01 ↑Up 
TXN thioredoxin ENSMUSG00000028367 -0.377 4.42E-01 ↑Up 
 
Table 2: EtOH regulation of Nrf2 transcripts. 
Exp Log Ratio- IPA data from RNA-seq results. The “Expected” column contains 
predicted direction of transcript expression if Nrf2 pathway were activated. Bold 
indicates proteins used in IB studies (Figure 11).  The transcript for Nrf2, 
NFE2L2, was upregulated in contrast to the downregulation of many Nrf2 target 






Figure 11: Immunoblot validation of EtOH-induced Nrf2 pathway changes. 
IPA canonical pathways analysis results suggested some Nrf2 gene products 
were down-regulated with EtOH exposure in the kidney. Western blot analyses 
confirm differences as highlighted in Table 1. Differential abundance of Nrf2 
target proteins (NQO1 (n=7), SOD1 (n=7), and GCLC (n=4)) confirmed proteomic 
observations for both EtOH + Ctl and EtOH + Ctl plus LPS (4h).  
Statistical differences were determined using students t-test or 2-way ANOVA.  
Catalase activity in renal cortical tissue. Catalase activity was decreased (2-
way ANOVA, *= p-value<0.05) in renal cortical tissue of EtOH-fed mice. Catalase 
activity was not statistically significantly affected by LPS. This pattern of catalase 
activity is consistent with the IB data for catalase abundance. Activity based on 
0.8 µg tissue lysate.
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The first aim of this work was to develop and characterize a method of hepatic ECM protein 
extraction and analysis that would provide both the sensitivity to identify low abundance proteins 
and the power to observe global changes in the ECM.  As mentioned in the Introduction, the 
study of hepatic ECM proteins has largely been ‘collagenocentric’ and ‘fibrosocentric’ – that is, 
centered on the dramatic increase in collagen deposition during fibrosis, a quasi-permanent 
scarring of the organ.  However, the matrisome of the healthy and diseased liver is significantly 
more diverse than collagen ECM.  Indeed, studies have shown that in addition to collagen, 
laminin (24) and vitronectin (25;26) are also increased during fibrogenesis.  Furthermore, 
proteomic-based studies in other organs have demonstrated that the matrisome responses 
dynamically in composition after insult well before fibrotic changes to the organ (14;18;27).  
Previously, this group has shown that fibrin ECM accumulation correlates with inflammatory liver 
injury in several models, and may well play a causal role in hepatic damage (6).  Additionally, 
Gillis et al. (5) have shown a similar role for fibronectin ECM in experimental ALD.  However, little 
is known about global changes in the hepatic ECM during inflammatory liver injury.   
Global changes in the ECM may mediate tissue function via mechanisms that fall generally 
into three categories, including physical, biochemical, and signaling mechanisms.  Physical 
properties of the ECM include the matrix topography, organization, and crosslinking (2).  These 
physical properties support the structural role of the ECM, but can also regulate cell migration 
both by serving as a physical barrier or facilitator to that function (28).  Fibrin matrices have been 
shown to be permissive to chemotaxis and activation of monocytes and leukocytes (29;30).  
Physical changes in the ECM can cause tissue rigidity resulting in reduced organ function.  
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Although such physical changes to the ECM can of course indirectly influence the 
biochemistry of the liver (e.g., hemostasis-induced hypoxia), changes to the mastrisome can also 
directly cause biochemical changes that are independent of structural changes.  For example, 
ECM components can facilitate interactions between ligands and receptors (31), bind and retain 
chemokines (1), and regulate activation of growth factors (i.e. TGFβ).(1)  ECM molecules can 
also directly serve as signaling molecules via interactions with cell surface receptors, including 
integrins.(32)  Because of the multi-faceted roles of many ECM molecules, any single change in 
the ECM can in principle trigger a cascade of dependent changes that influence the composition 
and properties of the ECM.  For example, biglycan serves as a structural component that 
regulates collagen fiber assembly but upon release from the matrix by can serve as a signaling 
molecule binding to TLR4 receptors (33).   
In the current study, the individual and combined effects of two experimental exposures 
(ethanol and LPS) on the hepatic matrisome were determined.  The rationale for selecting LPS is 
that it induces a robust inflammatory response in the liver.  The liver is often exposed to LPS 
during several pathophysiologic states, including after alcohol consumption (34).  Whereas 
inflammatory responses triggered by small doses of LPS are typically non-injurious, other 
stresses can synergistically enhance the hepatotoxic response to LPS.  Indeed, in addition to 
increasing circulating LPS, ethanol also enhances inflammation and liver damage caused by 
acute LPS exposure (22).  This ‘2-hit’ paradigm is a common factor in fatty liver diseases (35).  
The results here demonstrate that the hepatic matrisome responded dynamically to both 
stresses, not only increasing the net amount of protein associated with the matrisome, but also 
differentially changed the amounts (Figure 6) and likely the composition (Figures 5 and 6) of the 
proteins found.   
This study validated changes in the hepatic matrisome that have been reported previously 
after LPS and/or ethanol exposure.  For example, this work validated that the fibrin(ogen) ECM is 
dramatically altered by LPS and enhanced by the combination of ethanol and LPS(36).  In the 
current study, LPS exposure increased the amount of fibrinogen gamma chain detected in the 
GnHCl extract.  The fibrin(ogen) gamma chain is a major component of fibrin clots, as it is 
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polymerized into insoluble fibrin fibers (37).  Therefore, the localization of this robust increase in 
fibrinogen gamma chain in the GnHCl fractions suggests that there was an increase in 
fibrin(ogen) gamma chain polymerization into a less-soluble and more highly cross-linked form.  
Furthermore, the combination of ethanol and LPS resulted in presence of the fibrin(ogen) gamma 
chain in the insoluble pellet, which suggests additional modifications that increased insolubility 
(e.g., crosslinking).  The appearance of serum amyloid A-1 and A-2 proteins in response to LPS 
was also confirmed here (38;39).  In fact, LPS administration here increased the detection of 
several other acute phase proteins, including haptoglobin, complement C, and ceruloplasmin, 
which are all known to be increased by LPS exposure (40-42).  This work validates previous 
studies with ethanol, which demonstrated increased fibronectin deposition prior to the onset of 
fibrosis (5).   
This technique also identified novel changes caused by ethanol and LPS.  For example, 
vitronectin accumulation has previously been linked to hepatic fibrosis and end-stage liver 
disease (43;44).  The findings of the current study suggest that more subtle changes in vitronectin 
expression occur prior to the onset of fibrosis and hepatic decompensation.  Ethanol exposure 
also resulted in the appearance of galectin-1.  Galectin-1 is glycosaminoglycan-binding lectin 
associated with cell proliferation and adhesion through modulation of glycoprotein crosslinking.  
Galectin-1 may also play a role in hepatic inflammation and fibrinogenesis (45).  These data 
suggest that ethanol and/or LPS is likely contributing to a myriad of changes in the ECM 
composition, many of which have not yet been fully investigated. 
Changes in expression of protease and protease inhibitors can also contribute to 
inflammatory liver injury and fibrogenesis.  In the current study, several ECM-associated 
proteases were increased in response to stress, including plasmin(ogen), antithrombin III, 
dipeptidyl peptidase, and alpha-1-antitrypsin.  Stress also resulted in the presence of protease 
inhibitors, such as serpine B5 (maspin) and PAI-1.  Several other proteases and protease 
inhibitors that may be critical for ECM homeostasis [e.g., transthyretin, phosphatidylethanolamin-
binding protein-1 (PEBP1), and serine protease inhibitor A2K] increased in response to ethanol 
and/or LPS.  These data support the notion that transitional remodeling of the hepatic matrisome 
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is likely bidirectional and driven by both increased secretion of matrix proteins as well as changes 
in ECM degradation.   
As mentioned above, ethanol is well-known to synergize liver damage caused by LPS 
exposure.  In the current study, the combination of ethanol and LPS resulted in unique changes 
to the hepatic matrisome compared to either ethanol or LPS alone.  Indeed, fibronectin and 
biglycan expression were all differentially increase by co-exposure (Figure 4).  Fibronectin 
accumulation caused by ethanol may contribute to hepatic inflammation via stimulation of Kupffer 
cells (46).  Biglycan is a small proteoglycan was first recognized as a structural component and 
signaling molecule in the ECM (47), but has also been implicated in inflammation (48), potentially 
by retaining pro-inflammatory cytokines (49) and/or by activating TLR4 signaling (50).  These 
data suggest that biglycan expression may be increased in pre-fibrotic stages of liver disease.  In 
contrast, the combination of ethanol and LPS synergistically decreased 
phosphatidylethanolamine-binding protein-1 (PEBP1); this enzyme has been shown to inhibit 
trypsin-like serine proteases including thrombin, but not trypsin or tissue-type plasminogen 
activator (51).  Multiple studies have identified PEBP1 as a critical player in metastasis (52), and 
have defined it as a metastasis suppressor gene (53).  The implications of these changes will be 
pursued in future studies. 
Although chronic moderate alcohol consumption causes steatohepatitis, the effects on the 
kidney at the tissue level are currently indiscernible, in contrast to subtle changes caused by 
acute LPS exposure.  As such, these results are consistent with population data on the effects of 
moderate drinking on the kidney (8).   
Moderate, chronic alcohol consumption is known to prime other organs such as the liver and 
the lung for injury following a ‘second hit’.  IPA results suggests that EtOH, LPS, EtOH+LPS have 
differential effects on unique protein canonical pathways related to stress response, for example: 
inactivation of Nrf2 by EtOH or peroxisome proliferator-activated receptor (PPARα) /retinoid x 
receptor (RXRα) by LPS and activation of the acute phase response or liver x receptor 
(LXR)/RXR by LPS. 
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SUMMARY AND CONCLUSIONS 
 
STRENGTHS OF THIS WORK 
One overall strength of this work is the use of a discovery-based ‘omics approach, which is 
not limited by the current knowledge based compared to hypothesis-driven approaches.  
Additionally, this type of work provides the foundation for many new hypotheses. 
In summary, the results demonstrate that the hepatic matrisome responds dynamically to 
both acute (LPS) and chronic (ethanol) stresses, prior to more dramatic fibrotic changes to the 
liver.  It is likely that these transitional changes to the hepatic ECM contribute to the pathologic 
responses to these stresses.  It is also interesting that several ECM proteins responded similarly 
to both stresses, suggesting a common mechanism in both models.  The changes in proteins that 
were unique to either exposure alone (or their combination) also represents potential new 
biomarkers or targets.  These results therefore also serve as a foundation for future analyses in 
hepatic models of liver disease. 
This work also demonstrates that although moderate, chronic alcohol consumption does not 
cause noticeable tissue-level changes in the kidney, alcohol does cause protein-level changes.  
Most notably, ethanol was shown to dysregulate the Nrf2-mediated oxidative stress response 
pathway in the renal cortex, whether or not LPS was also administered.  The importance of the 
Nrf2 pathway has been established in many disease states (54;55;55;56), and so this work 
suggests moderate alcohol consumption may affect Nrf2-related pathologies in the kidney.    
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CAVEATS AND WEAKNESSES  
This work used a mouse model of chronic, moderate alcohol consumption.  Therefore, the 
changes identified in both the liver and kidney studies may not necessarily be relevant to binge 
drinking.  However, acute and chronic models of alcohol consumption have great mechanistic 
overlap, as evidenced by studies of protective agents in both types of models (57;58)The renal 
cortex proteomic data are limited by the use of whole cortical tissue for discovery proteomics and 
the use of TMT isobaric labeling reagents which can lead to compression of observed reporter ion 
differences.  Despite these limitations, we have confirmed multiple observations of the effect of 
EtOH and LPS on protein abundance.   
 
FUTURE DIRECTIONS 
Future directions for the investigation of the effects EtOH on the hepatic transitional ECM 
include determining the critical roles of the identified proteins in EtOH-induced liver injury.  Future 
directions for the investigation of the effects of EtOH on the renal cortex proteome include 
determining the role of the proteosome versus autophagy for EtOH induced loss of catalase and 
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